Dow Up0.76% Nasdaq Up0.69%

Taro Pharmaceutical Industries Ltd. (TARO)

-NYSE
150.00 Up 3.74(2.56%) Oct 24, 4:02PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Mar 31, 2013Mar 31, 2012
Total Revenue 759,285   670,954   145,141  
Cost of Revenue179,279  176,128  45,971  
Gross Profit 580,006   494,826   99,170  
Operating Expenses
Research Development55,430  46,508  9,847  
Selling General and Administrative94,323  119,738  23,101  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 430,253   328,580   66,222  
Income from Continuing Operations
Total Other Income/Expenses Net1,369  3,352  (94)
Earnings Before Interest And Taxes443,907  335,863  65,128  
Interest Expense -   -   -  
Income Before Tax443,907  335,863  65,128  
Income Tax Expense82,729  67,799  17,791  
Minority Interest(472)(664)(151)
Net Income From Continuing Ops361,178  268,064  47,337  
Non-recurring Events
Discontinued Operations(319)(1,194)66  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 360,387   266,206   47,252  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 360,387   266,206   47,252  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.